BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 16154665)

  • 1. [Pravastatin-induced dermatomyositis].
    Zuech P; Pauwels C; Duthoit C; Méry L; Somogyi A; Louboutin A; Veyssier-Belot C
    Rev Med Interne; 2005 Nov; 26(11):897-902. PubMed ID: 16154665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pravastatin-associated polymyositis, a case report].
    Takagi A; Shiio Y
    Rinsho Shinkeigaku; 2004 Jan; 44(1):25-7. PubMed ID: 15199734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute pancreatitis due to pravastatin therapy.
    Anagnostopoulos GK; Tsiakos S; Margantinis G; Kostopoulos P; Arvanitidis D
    JOP; 2003 May; 4(3):129-32. PubMed ID: 12743419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Fluvastatin-induced dermatomyositis].
    Thual N; Penven K; Chevallier JM; Dompmartin A; Leroy D
    Ann Dermatol Venereol; 2005 Dec; 132(12 Pt 1):996-9. PubMed ID: 16446645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparison of 2 cholesterol synthesis inhibitors (simvastatin and pravastatin)].
    Golay A; Lehmann T; James R; Pometta D
    Schweiz Med Wochenschr; 1993 Aug; 123(33):1553-8. PubMed ID: 8372340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. More on PROSPER.
    Baztán JJ; Hornillos M; Rodríguez-Mañas L
    Lancet; 2003 Mar; 361(9363):1135; author reply 1136. PubMed ID: 12672345
    [No Abstract]   [Full Text] [Related]  

  • 7. Tolerability and effects on lipids of ezetimibe coadministered with pravastatin or simvastatin for twelve months: results from two open-label extension studies in hypercholesterolemic patients.
    Strony J; Hoffman R; Hanson M; Veltri E
    Clin Ther; 2008 Dec; 30(12):2280-97. PubMed ID: 19167588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pravastatin: a potential cause for acute pancreatitis.
    Tsigrelis C; Pitchumoni CS
    World J Gastroenterol; 2006 Nov; 12(43):7055-7. PubMed ID: 17109506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-density lipoprotein cholesterol (LDL-C) levels and LDL-C goal attainment among elderly patients treated with rosuvastatin compared with other statins in routine clinical practice.
    Harley CR; Gandhi S; Blasetto J; Heien H; Sasane R; Nelson SP
    Am J Geriatr Pharmacother; 2007 Sep; 5(3):185-94. PubMed ID: 17996658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Simvastatin-induced dermatomyositis].
    Rasch A; Schimmer M; Sander CA
    Hautarzt; 2009 Jun; 60(6):489-93. PubMed ID: 18853127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Statins as new therapeutic possibility in osteoporosis?].
    Laufs U; Werner N; Böhm M; Nickenig G
    Dtsch Med Wochenschr; 2001 May; 126(19):565-8. PubMed ID: 11402915
    [No Abstract]   [Full Text] [Related]  

  • 12. Efficacy and safety of high-dose pravastatin in hypercholesterolemic patients with well-compensated chronic liver disease: Results of a prospective, randomized, double-blind, placebo-controlled, multicenter trial.
    Lewis JH; Mortensen ME; Zweig S; Fusco MJ; Medoff JR; Belder R;
    Hepatology; 2007 Nov; 46(5):1453-63. PubMed ID: 17668878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mood stabilizer therapy and pravastatin: higher risk for adverse skin reactions?
    Walder A; Baumann P
    Acta Medica (Hradec Kralove); 2009; 52(1):15-8. PubMed ID: 19754002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does statin therapy influence steroid hormone synthesis?
    Böhm M; Herrmann W; Wassmann S; Laufs U; Nickenig G
    Z Kardiol; 2004 Jan; 93(1):43-8. PubMed ID: 14740240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute cholestatic hepatitis associated with pravastatin.
    Hartleb M; Rymarczyk G; Januszewski K
    Am J Gastroenterol; 1999 May; 94(5):1388-90. PubMed ID: 10235223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cardiovascular pharmacology (VIII). The role of HMG CoA reductase inhibitors in the current treatment of hyperlipidemias].
    Carmena R
    Rev Esp Cardiol; 1995 Jan; 48(1):59-65. PubMed ID: 7878284
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical evaluation of a selective inhibitor of cholesterol synthesis: pravastatin].
    Alessandri C; Peverini F
    Minerva Med; 1992 Nov; 83(11):677-93. PubMed ID: 1461539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A review of clinical trials comparing HMG-CoA reductase inhibitors.
    Illingworth DR; Tobert JA
    Clin Ther; 1994; 16(3):366-85; discussion 365. PubMed ID: 7923304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Recurrent acute pancreatitis during pravastatin-therapy].
    Becker C; Hvalic C; Delmore G; Krähenbühl S; Schlienger R
    Praxis (Bern 1994); 2006 Jan; 95(4):111-6. PubMed ID: 16485606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simvastatin versus pravastatin: efficacy and tolerability in patients with primary hypercholesterolemia.
    Malini PL; Ambrosioni E; De Divitiis O; Di Somma S; Rosiello G; Trimarco B
    Clin Ther; 1991; 13(4):500-10. PubMed ID: 1934003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.